Aurora Cannabis’ (NASDAQ: ACB) (TSX: ACB) bet on selling prescription cannabis in places like Germany and Australia is returning results, with third-quarter overseas sales more than doubling versus last year.
The Canadian cannabis producer posted record profits and revenue in its latest quarter, driven by surging international medical marijuana sales that…
Please login to read all 549 words.
